InventionMed S.A. (WSE:INM)

Poland flag Poland · Delayed Price · Currency is PLN
0.1545
-0.0010 (-0.64%)
At close: Oct 10, 2025
-0.64%
Market Cap31.33M
Revenue (ttm)2.01M
Net Income (ttm)-3.73M
Shares Out202.79M
EPS (ttm)-0.02
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume173,320
Average Volume228,537
Open0.1540
Previous Close0.1555
Day's Range0.1500 - 0.1560
52-Week Range0.1495 - 0.2350
Beta0.15
RSI43.59
Earnings DateNov 14, 2025

About InventionMed

InventionMed S.A. focuses on the development of medical simulators based on Virtual Realty technology for use in education in esthetic and clinical dermatology. Its flagship project is TutorDerm, a simulator and an application that lets users perform actions necessary to treat specific dermatological diseases. The company also offers double immersion, and Virtual Syringe, a training equipment for specialists in clinical and aesthetic dermatology. InventionMed S.A. was incorporated in 2012 and is based in Bydgoszcz, Poland. [Read more]

Sector Healthcare
Founded 2012
Employees 5
Stock Exchange Warsaw Stock Exchange
Ticker Symbol INM
Full Company Profile

Financial Performance

In 2024, InventionMed's revenue was 277,760, an increase of 45810.74% compared to the previous year's 605. Losses were -4.41 million, 133.2% more than in 2023.

Financial Statements

News

There is no news available yet.